Whether nosocomial infections, travel-related illness, or emerging or reemerging threats, as health care professionals it is important to remain vigilant about the threats our patients face; be aware of the situations they can become involved which increase risk of infections; be knowledgeable about proper preventive, reporting, and treatment strategies; and avoid the notion that oceans and geography protect us from global pathogens that heretofore we have had past success in reducing or containing.

It is also important to recognize old, but reemerging pathogens, such as whooping cough/pertussis, which can be overlooked when patients present with upper respiratory illnesses, especially when taking into account that vaccination protection wanes over time, and adult vaccination rates are not optimized.

We as health care professionals have a responsibility to and play an important role in limiting the spread of disease, to assist in local preparedness efforts, provide appropriate educational information and medical care to patients, promote the use of vaccines and other preventive measures, including social distancing and hygiene practices, and set the stage for rapid recovery.

Part I of this Disease-a-Month two-part series on emerging infectious diseases provides a background and approach to the growing threat of new global as well as old but reemerging infections, and an in-depth discussion of important and potentially deadly emerging pathogens and travel-related illnesses. Additionally this is an update and review of an underappreciated global threat that is positioned to cause more frequent outbreaks in the United States---Dengue---a Flavivirus known to afflict hundreds of millions worldwide.

In Part II, two newly discovered viruses will be discussed, along with their more common and less pathogenic versions---Middle East respiratory syndrome coronavirus (MERS CoV), a new coronavirus reminiscent of but distinct from the severe acute respiratory syndrome (SARS) coronavirus, a pathogen that caused a worldwide public health emergency in 2003 and novel avian influenza H7N9 that is reminiscent of but distinct from earlier avian influenza viruses. These two viruses, MERS CoV and H7N9, like other pathogens before them, have the potential to cause sustained global suffering and serve as reminders that the struggle to control infections and prevent global outbreaks is a daily one.

As a crossroads of travel, international finance and trade, overcrowding of health care facilities, an overburdened public health system, growing immigration from impoverished nations, and persistent pockets of poverty, the United States is no longer isolated from global infectious diseases. The prudent clinician should consider a broader range of pathogens, based upon endemic infections from nations of travel/immigration origin, patient population, and emerging patterns of illness in your community.
